Determinants of left ventricular dysfunction after repair of chronic asymptomatic mitral regurgitation
- PMID: 25442982
- DOI: 10.1016/j.athoracsur.2014.07.025
Determinants of left ventricular dysfunction after repair of chronic asymptomatic mitral regurgitation
Abstract
Background: The evidence supporting early surgical intervention in patients with chronic asymptomatic mitral regurgitation (MR) is steadily accumulating. Although left ventricular (LV) enlargement and preoperative pulmonary hypertension are considered when deciding on surgical intervention, the threshold above which these factors influence clinical outcomes remains poorly defined.
Methods: One-hundred fifty asymptomatic patients of aged 59.3 ± 13.4 years underwent mitral valve repair of severe MR caused by myxomatous degeneration between 2001 and 2012. Mean preoperative left atrial diameter, LV end-systolic diameter (LVESD), and right ventricular systolic pressure were 41.2 ± 6.9 mm, 34.6 ± 5.4 mm, and 38.4 ± 11.8 mm Hg, respectively. Preoperative LV ejection fraction (LVEF) was greater than 60% in 136 (91%) patients, and none had preoperative atrial fibrillation. Clinical and echocardiographic follow-up averaged 3.3 years and extended to 9.1 years.
Results: There were no perioperative deaths. Five-year survival and freedom from recurrent MR greater than or equal to 2+ were 93.4% ± 3.2% and 94.0% ± 3.2%, respectively. A threshold LVESD indexed to body surface area greater than 19 mm/m(2) (hazard ratio [HR], 3.5 ± 2.0; p = 0.03) and a preoperative right ventricular systolic pressure greater than 45 mm Hg (HR, 3.8 ± 12.1; p = 0.01) were independently associated with postoperative LV dysfunction, defined as a LVEF less than 60%.
Conclusions: Mitral valve repair can be performed with favorable early and late outcomes in patients with asymptomatic severe MR. The presence of minimal LV enlargement and preoperative pulmonary hypertension were associated with postoperative LV dysfunction in this otherwise healthy population. Mitral valve repair may be considered in asymptomatic patients with an indexed LVESD (ILVESD) greater than 19 mm/m(2) or preoperative right ventricular systolic pressure greater than 45 mm Hg.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Comment in
-
About the Decision-Making Process for Mitral Valve Repair.Ann Thorac Surg. 2017 Sep;104(3):1095. doi: 10.1016/j.athoracsur.2016.11.044. Ann Thorac Surg. 2017. PMID: 28838489 No abstract available.
-
Reply.Ann Thorac Surg. 2017 Sep;104(3):1095. doi: 10.1016/j.athoracsur.2016.12.033. Ann Thorac Surg. 2017. PMID: 28838491 No abstract available.
Similar articles
-
Left ventricular dysfunction after mitral valve repair--the fallacy of "normal" preoperative myocardial function.J Thorac Cardiovasc Surg. 2014 Dec;148(6):2752-60. doi: 10.1016/j.jtcvs.2014.07.029. Epub 2014 Jul 31. J Thorac Cardiovasc Surg. 2014. PMID: 25173130
-
Timing of valve repair for severe degenerative mitral regurgitation and long-term left ventricular function.J Thorac Cardiovasc Surg. 2014 Nov;148(5):1978-82. doi: 10.1016/j.jtcvs.2014.01.041. Epub 2014 Feb 4. J Thorac Cardiovasc Surg. 2014. PMID: 24589200
-
Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.Heart Surg Forum. 2012 Jun;15(3):E127-32. doi: 10.1532/HSF98.20121008. Heart Surg Forum. 2012. PMID: 22698598
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
Is there a role for biomarkers in asymptomatic severe chronic primary mitral regurgitation?Curr Opin Cardiol. 2023 Mar 1;38(2):68-74. doi: 10.1097/HCO.0000000000001016. Epub 2023 Jan 11. Curr Opin Cardiol. 2023. PMID: 36633320 Review.
Cited by
-
Longitudinal Outcomes Following Surgical Repair of Primary Mitral Regurgitation.J Cardiovasc Dev Dis. 2023 Feb 23;10(3):95. doi: 10.3390/jcdd10030095. J Cardiovasc Dev Dis. 2023. PMID: 36975860 Free PMC article. Review.
-
Mitral stenosis in a teenager after rheumatic mitral valve regurgitation valve repair: A case report.Front Cardiovasc Med. 2022 Dec 15;9:978874. doi: 10.3389/fcvm.2022.978874. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36588572 Free PMC article.
-
Risk factors of chronic left ventricular dysfunction after cardiac valve surgery.J Thorac Dis. 2020 Sep;12(9):4854-4859. doi: 10.21037/jtd-20-1010. J Thorac Dis. 2020. PMID: 33145058 Free PMC article.
-
Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes.J Cardiothorac Surg. 2020 Oct 1;15(1):284. doi: 10.1186/s13019-020-01309-6. J Cardiothorac Surg. 2020. PMID: 33004041 Free PMC article.
-
Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial).BMJ Open. 2017 May 30;7(5):e015032. doi: 10.1136/bmjopen-2016-015032. BMJ Open. 2017. PMID: 28566364 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
